Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Research

• Publication date

  2002-11-15

• Fields of study

  Medicine

• Identifiers
  PMID 12438226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minimal Residual Disease in Head and Neck Cancer

  2004cited by this paper
• Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer.

  2002cited by this paper
• Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue.

  2001cited by this paper
• Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer

  2001cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging

  2000cited by this paper
• Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.

  2000cited by this paper
• Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.

  2000cited by this paper
• Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma

  1999cited by this paper
• Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.

  1999cited by this paper
• p53 regulates a G2 checkpoint through cyclin B1.

  1999cited by this paper
• Cumulative prognostic value of p53 mutations and bcl‐2 protein expression in head‐and‐neck cancer treated by radiotherapy

  1999cited by this paper
• Mechanisms of G2 arrest in response to overexpression of p53.

  1999cited by this paper
• Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation.

  1997cited by this paper
• The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B.

  1994cited by this paper
• Head and Neck Cancer

  1993cited by this paper
• Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.

  1993cited by this paper
• Animal cell cycles and their control.

  1992cited by this paper
• Significance of positive margins in oral cavity squamous carcinoma.

  1990cited by this paper
• The Biological Basis of Radiotherapy

  1989cited by this paper
• Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy.

  1988cited by this paper
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

  1988cited by this paper
• Inherently radioresistant cells exist in some human tumors.

  1985cited by this paper
• Significance of Positive Bronchial Cytology in Presence of Squamous Cell Carcinoma of Upper Aerodigestive Tract

  1981cited by this paper
• Perineural spread in squamous cell carcinomas of the head and neck: a clinicopathological study.

  1979cited by this paper
• The significance of "positive" margins in surgically resected epidermoid carcinomas.

  1978cited by this paper
• Carcinoma of the oral cavity. factors affecting treatment failure at the primary site and neck.

  1976cited by this paper
• Epidermoid carcinoma of the mouth and pharynx 1960–1964

  1972cited by this paper
• BASIC SCIENCE REVIEW

  year unknowncited by this paper

• Suppression of Cellular Proliferation in PC3 Prostate Cancer Cells by Green Tea Extract Through Induction of miR‐34a Expression

  2025cites this paper
• Identification of Prognosis-Related Genes and Key Target Genes for Pancreatic Cancer: A Bioinformatics Analysis

  2024cites this paper
• Nanomaterials for refining tumor microenvironment and enhancing therapy in head and neck squamous cell carcinoma: a review

  2024cites this paper
• CircCDYL2 bolsters radiotherapy resistance in nasopharyngeal carcinoma by promoting RAD51 translation initiation for enhanced homologous recombination repair

  2024cites this paper
• CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer

  2024cites this paper
• Prognostic value of hypoxia-responsive gene expression profile in patients diagnosed with head and neck squamous cell carcinoma

  2023cites this paper
• Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review

  2023cites this paper
• Cell Cycle-Related Clinical Applications.

  2022cites this paper
• CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine

  2022cites this paper
• M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression.

  2022cites this paper
• Anticancer effects of picrasidine I on oral squamous cell carcinoma

  2021cites this paper
• Targeting cell-cycle machinery in cancer.

  2021cites this paper
• Clinical Significance of Cyclin Expression Profiling in Ocular Surface Squamous Neoplasia

  2021cites this paper
• Induction of Mitosis Delay and Apoptosis by CDDO-TFEA in Glioblastoma Multiforme

  2021cites this paper
• Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1

  2021cites this paper
• Prevalence and Detection of Sexually Transmitted Cases of Laryngeal Carcinoma

  2020cites this paper
• Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma

  2020influential citation
• Mesenchymal epithelial transition factor regulates tumor necrosis factor-related apoptotic induction ligand resistance in hepatocellular carcinoma cells through down-regulation of cyclin B1.

  2020cites this paper
• Inhibition of cyclinB1 Suppressed the Proliferation, Invasion, and Epithelial Mesenchymal Transition of Hepatocellular Carcinoma Cells and Enhanced the Sensitivity to TRAIL-Induced Apoptosis

  2020cites this paper
• Mechanism for allicin to sensitize gastric cancer cells to chemotherapy

  2019cites this paper
• Synergistic inhibition of melanoma xenografts by Brequinar sodium and Doxorubicin.

  2019cites this paper
• Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance.

  2019cites this paper
• Expression of Concern: Cyclin B1/Cdk1 Phosphorylation of Mitochondrial p53 Induces Anti-Apoptotic Response

  2019cites this paper
• Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers

  2018cites this paper
• STIL balancing primary microcephaly and cancer

  2018cites this paper
• Downregulation of Cyclin B1 mediates nagilactone E‐induced G2 phase cell cycle arrest in non‐small cell lung cancer cells

  2018cites this paper
• FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.

  2018cites this paper
• TARGETING CYCLIN B1 WITH ANTISENSE OLIGONUCLETOTIDES- COATED SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES

  2018cites this paper
• Prognostic Significance of Cyclins A2, B1, D1, and E1 and CCND1 Numerical Aberrations in Oral Squamous Cell Carcinomas

  2018cites this paper
• Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis

  2018cites this paper
• Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway

  2017cites this paper
• Immunohistochemical Expression of Cyclin B1 in Epithelial Hyperplasia, Dysplasia and Oral Squamous Cell Carcinomas - A Comparative Study.

  2016cites this paper
• Upregulation of BTG1 enhances the radiation sensitivity of human breast cancer in vitro and in vivo.

  2015cites this paper
• Upregulation of BTG 1 enhances the radiation sensitivity of human breast cancer in vitro and in vivo

  2015cites this paper
• Radioresistance in Head and Neck Squamous Cell Carcinoma — Possible Molecular Markers for Local Recurrence and New Putative Therapeutic Strategies

  2015cites this paper
• RAD001 enhances the radiosensitivity of SCC4 oral cancer cells by inducing cell cycle arrest at the G2/M checkpoint.

  2014cites this paper
• CCNB1 is a prognostic biomarker for ER+ breast cancer.

  2014cites this paper
• Molecular mechanisms and tumour heterogeneity in breast cancer

  2014cites this paper
• RAD 001 Enhances the Radiosensitivity of SCC 4 Oral Cancer Cells by Inducing Cell Cycle Arrest at the G 2 / M Checkpoint

  2014cites this paper
• Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

  2014cites this paper
• Cell Cycle Regulators Guide Mitochondrial Activity in Radiation-Induced Adaptive Response

  2014cites this paper
• Cyclin B1 overexpression in conventional oral squamous cell carcinoma and verrucous carcinoma-A correlation with clinicopathological features

  2013cites this paper
• Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells

  2013cites this paper
• Inhibition of autophagy by 3-MA enhances endoplasmic reticulum stress-induced apoptosis in human nasopharyngeal carcinoma cells

  2013cites this paper
• Prognostic Value of Discs Large Homolog 7 Transcript Levels in Prostate Cancer

  2013cites this paper
• Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition.

  2013cites this paper
• Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases

  2013cites this paper
• miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer

  2013cites this paper
• Cell cycle-regulatory cyclins and their deregulation in oral cancer.

  2013cites this paper
• Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor

  2012cites this paper
• In vitro growth inhibition of human cancer cells by novel honokiol analogs.

  2012cites this paper
• FoxM1 mediated resistance to gefitinib in non-smallcell lung cancer cells

  2012cites this paper
• SPARC expression induces cell cycle arrest via STAT3 signaling pathway in medulloblastoma cells.

  2012cites this paper
• Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells.

  2012cites this paper
• Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma

  2012cites this paper
• Cyclins and cell cycle control in cancer and disease.

  2012cites this paper
• The mechanisms of reversal of refractory dysplasia in the salivary gland: Testing the role of p53, RXR and PPARgamma agonists, and PD0332991

  2012cites this paper
• Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck.

  2011cites this paper
• The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line.

  2011cites this paper
• The role of Sonic Hedgehog as a regulator of adult stomach physiology

  2011cites this paper
• Induction of apoptotic cell death by phytoestrogens by up-regulating the levels of phospho-p53 and p21 in normal and malignant estrogen receptor α-negative breast cells.

  2011cites this paper
• Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1

  2010cites this paper
• Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets.

  2010cites this paper
• Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer

  2010cites this paper
• Effect of intratumoral injection of mutant type p27Kip1 followed by in vivo electroporation on radiotherapy-resistant human oral tongue cancer xenografts.

  2010cites this paper
• Cyclin B1/Cdk1 Phosphorylation of Mitochondrial p53 Induces Anti-Apoptotic Response

  2010cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2009cites this paper
• Expression modes and clinical manifestations of latent membrane protein 1, Ki‐67, cyclin‐B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma

  2009cites this paper
• Expression of histone H3, p53, cyclin D1, and cyclin B1 in oral mucosal lesions

  2009cites this paper
• Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay

  2009cites this paper
• Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor

  2009cites this paper
• Immunity against Cyclin B1 Tumor Antigen Delays Development of Spontaneous Cyclin B1‐Positive Tumors in p53−/− Mice

  2009cites this paper
• Differential expression profiling of gene response to ionizing radiation in two endometrial cancer cell lines with distinct radiosensitivities.

  2009cites this paper
• NF-κB-mediated adaptive resistance to ionizing radiation

  2008cites this paper
• Molecular signatures of metastasis in head and neck cancer

  2008cites this paper
• Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice

  2008cites this paper
• Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol

  2008cites this paper
• NF-kappa B-mediated adaptive resistance to ionizing radiation.

  2008cites this paper
• Cyclin B1: Abnormal Self /Tumor Antigen

  2008cites this paper
• Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor

  2007cites this paper
• Nuclear factor-kappaB and manganese superoxide dismutase mediate adaptive radioresistance in low-dose irradiated mouse skin epithelial cells.

  2007influential citation
• Share your knowledge , it is a way to achieve immortality !

  2007cites this paper
• Nasopharyngeal carcinoma: past, present and future directions

  2007cites this paper
• Oral cancer proteomics.

  2007cites this paper
• Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy

  2007cites this paper
• Evaluation of CDK Inhibitor Selectivity: From Affinity Chromatography to Yeast Genetics

  2006cites this paper
• Cyclin-Dependent Kinase Small Molecule Modulators for Cancer Therapy

  2006cites this paper
• HER-2 and NF-κB as the Targets for Therapy-resistant Breast Cancer

  2006cites this paper
• Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients

  2006cites this paper
• Cell Cycle Dynamics and the Challenges for CDK Targeting

  2006cites this paper
• HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.

  2006cites this paper
• Head and neck squamous cell carcinoma : Mansoura 10 years experience

  2005cites this paper
• Co-activation of ERK, NF-κB, and GADD45β in Response to Ionizing Radiation*

  2005cites this paper
• Inhibition of the Growth of Premalignant and Malignant Human Oral Cell Lines by Extracts and Components of Black Raspberries

  2005cites this paper
• Mcl-1, Vascular Endothelial Growth Factor-R2, and 14-3-3σ Expression Might Predict Primary Response against Radiotherapy and Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck

  2005cites this paper
• Loss of Cyclin B1 followed by downregulation of Cyclin A/Cdk2, apoptosis and antiproliferation in Hela cell line

  2005cites this paper
• present and future directions

  2005cites this paper
• p73 is a p53-independent, Sp1-dependent repressor of cyclin B1 transcription.

  2005cites this paper
• PD.11 Head and neck squamous cell carcinoma: Mansoura 10 years experience

  2005cites this paper
• p53 is a NF‐Y‐ and p21‐independent, Sp1‐dependent repressor of cyclin B1 transcription

  2005cites this paper